CASSINI Trial publishes data on preventing blood clots in cancer patients: Study data could inform new guidelines for diagnosing, preventing and treating cancer patients at high risk of developing blood clots - Science Daily

CASSINI Trial publishes data on preventing blood clots in cancer patients: Study data could inform new guidelines for diagnosing, preventing and treating cancer patients at high risk of developing blood clots  Science Daily

Researchers have published the first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with ...



Comments

Post a Comment

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma    Global Banking And Finance Review Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Read more